[September 19, 2017]

Patient Derived Xenograft/PDX Models Market by Type, Tumor Type, Application, End User - Global Forecast to 2022 - Research and Markets

The "Patient Derived Xenograft/PDX Models Market - Global Forecast to 2022" report has been added to Research and Markets' offering.

The global PDX models market is expected to reach USD 167.6 Million by 2022 from USD 77.4 Million in 2017, at a CAGR of 16.7%

The key factors driving the growth of the overall PDX models market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. However, the high cost of personalized PDX models and stringent guidelines regarding the ethical use of animals in cancer research are expected to restrain the growth of this market during the forecast period.

Based on tumor type, the PDX models market is segmented into gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, and other tumor models suc as head & neck cancer, sarcoma, and melanoma. During the forecast period, the respiratory tumor models segment is expected to register the highest CAGR. Growth in this segment is mainly driven by the increasing focus of market players on generating lung cancer PDX models, which could lead to a breakthrough in lung cancer treatment, as lung cancer is the leading cause of cancer-related deaths across the globe.

Companies Mentioned

• Bioduro (Us)
• Champions Oncology Inc.
• Charles River Laboratories International Inc.
• Crown Bioscience Inc.
• Epo Berlin-Buch Gmbh
• Hera Biolabs
• Horizon Discovery Group Plc (Sage Labs Inc.)
• Oncodesign
• Pharmatest Services Ltd.
• Shanghai Lide Biotech Co. Ltd. (China)
• The Jackson Laboratory
• Urolead
• Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec)
• Xenopat (Spain)
• Xentech

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 PDX Models Market, By Type

7 PDX Models Market, By Tumor Type

8 PDX Models Market, By Application

9 PDX Models Market, By End User

10 PDX Models Market, By Region

11 Competitive Landscape

12 Company Profiles

13 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/778j5m/patient_derived

View source version on businesswire.com: http://www.businesswire.com/news/home/20170919006509/en/

[ Back To TMCnet.com's Homepage ]